A detailed history of Jnba Financial Advisors transactions in Novo Nordisk A S stock. As of the latest transaction made, Jnba Financial Advisors holds 4,187 shares of NVO stock, worth $494,987. This represents 0.06% of its overall portfolio holdings.

Number of Shares
4,187
Previous 5,574 24.88%
Holding current value
$494,987
Previous $715,000 16.5%
% of portfolio
0.06%
Previous 0.08%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024

SELL
$122.71 - $146.91 $170,198 - $203,764
-1,387 Reduced 24.88%
4,187 $597,000
Q1 2024

Apr 26, 2024

BUY
$102.11 - $135.92 $16,746 - $22,290
164 Added 3.03%
5,574 $715,000
Q4 2023

Feb 07, 2024

SELL
$87.78 - $105.45 $13,869 - $16,661
-158 Reduced 2.84%
5,410 $559,000
Q3 2023

Nov 02, 2023

BUY
$90.94 - $199.54 $253,176 - $555,519
2,784 Added 100.0%
5,568 $506,000
Q1 2023

May 01, 2023

SELL
$132.34 - $159.14 $3,308 - $3,978
-25 Reduced 0.89%
2,784 $443,000
Q4 2022

Feb 06, 2023

SELL
$102.55 - $135.33 $260,477 - $343,738
-2,540 Reduced 47.49%
2,809 $380,000
Q3 2022

Nov 07, 2022

SELL
$95.28 - $116.93 $115,574 - $141,836
-1,213 Reduced 18.49%
5,349 $533,000
Q2 2022

Jul 22, 2022

SELL
$103.24 - $121.81 $11,356 - $13,399
-110 Reduced 1.65%
6,562 $731,000
Q4 2020

Jan 25, 2021

BUY
$63.89 - $73.8 $19,167 - $22,140
300 Added 4.71%
6,672 $466,000
Q2 2019

Jul 26, 2019

BUY
$46.79 - $52.47 $30,179 - $33,843
645 Added 11.26%
6,372 $325,000
Q1 2019

May 01, 2019

BUY
$46.36 - $52.63 $242,323 - $275,097
5,227 Added 1045.4%
5,727 $300,000
Q4 2018

Feb 07, 2019

BUY
$41.54 - $47.25 $20,770 - $23,625
500 New
500 $23,000
Q3 2018

Nov 01, 2018

SELL
$46.76 - $51.24 $23,380 - $25,620
-500 Closed
0 $0
Q1 2018

May 07, 2018

SELL
$48.49 - $58.14 $30,063 - $36,046
-620 Reduced 55.36%
500 $500,000
Q3 2017

Nov 13, 2017

SELL
$41.15 - $49.22 $81,435 - $97,406
-1,979 Reduced 63.86%
1,120 $54,000
Q2 2017

Aug 14, 2017

BUY
N/A
3,099
3,099 $133,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $267B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Jnba Financial Advisors Portfolio

Follow Jnba Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jnba Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Jnba Financial Advisors with notifications on news.